merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The ruling casts a shadow on von der Leyen before a crucial vote on her future, potentially impacting her chances of securing a second term.</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<question_number>3</question_number>
<answer>Von der Leyen will likely need votes from center-left lawmakers including the Greens, who have been incensed by her handling of the coronavirus crisis.</answer>

<question_number>4</question_number>
<answer>Concerns about lack of transparency on vaccine contracts have contributed to distrust among European voters, amid a surge in far-right politicians gaining seats in the European Parliament.</answer>

<question_number>5</question_number>
<answer>N/A</answer>

<question_number>6</question_number>
<answer>The ruling came just ahead of a tight vote that will determine if von der Leyen will serve another term as the European Union's top official.</answer>

<question_number>7</question_number>
<answer>The EU's initial vaccine campaign was slow, but later caught up and surpassed other major countries after von der Leyen secured a contract with Pfizer-BioNTech.</answer>

<question_number>8</question_number>
<answer>The Commission claims to have provided "full information" to the European Parliament, despite the court ruling that it wrongly withheld information.</answer>

<question_number>9</question_number>
<answer>Both cases involve requests for access to information about vaccine negotiations led by von der Leyen.</answer>

<question_number>10</question_number>
<answer>The ruling may contribute to distrust among European voters about how officials have spent taxpayer money on vaccine procurement.</answer>